Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
DIFFDX
Show more
Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression
Class 44 – Medical & beauty services
Status timeline
- 19 Apr 2021Assigned to an examining attorneyAssigned To Examiner
- 20 Apr 2021Office action issuedNon-Final Action Written
- 18 Oct 2021Response to office action filedTeas Response To Office Action Received
- 18 Nov 2021Approved for registration (Supplemental Register)Approved For Registration Supplemental Register
- 28 Dec 2021Registered on the Supplemental RegisterRegistered-Supplemental Register
All 15 events
| 2022-09-13 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2022-09-13 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2022-09-13 | Teas Change Of Correspondence Received |
| 2021-12-28 | Registered-Supplemental Register |
| 2021-11-19 | Law Office Publication Review Completed |
| 2021-11-18 | Approved For Registration Supplemental Register |
| 2021-11-18 | Assigned To Lie |
| 2021-10-18 | Teas Response To Office Action Received |
| 2021-10-18 | Correspondence Received In Law Office |
| 2021-10-18 | Teas/Email Correspondence Entered |
| 2021-04-20 | Non-Final Action Written |
| 2021-04-20 | Non-Final Action E-Mailed |
| 2021-04-20 | Notification Of Non-Final Action E-Mailed |
| 2021-04-19 | Assigned To Examiner |
| 2021-01-13 | New Application Office Supplied Data Entered |
Goods & services by class
Class 44 Medical & beauty services
Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression
First use anywhere 3 Nov 2020 · First use in commerce 3 Nov 2020
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 28 Dec 2021; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.